Late onset lattice corneal dystrophy with systemic familial amyloidosis, amyloidosis V, in an English family

British Journal of Ophthalmology

Volumn 84, Issue 4, 2000, Pages 390-394

  Stewart, Helen S ^a,b   Parveen, Rahat ^a   Ridgway, Alan E ^c   Bonshek, Richard ^b,c   Black, Graeme C M ^a,c  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYLOIDOSIS; ARTICLE; CASE REPORT; CHROMOSOME 9Q; CORNEA DYSTROPHY; FAMILY; GENE MUTATION; GENE SEQUENCE; GENETIC LINKAGE; HUMAN; MALE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; UNITED KINGDOM;

AGE OF ONSET; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; CHROMOSOMES, HUMAN, PAIR 9; CORNEAL DYSTROPHIES, HEREDITARY; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE;

EID: 0034057570     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.4.390     Document Type: Article

References (30)

1. Munier FL, Korvatska E, Djemai A, et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet 1997;15:247-51.
2. Yamamoto S, Okada M, Tsujikawa M, et al. A kerato-epithelin (βig-h3) mutation in lattice corneal dystrophy type IIIA. Am J Hum Genet 1998; 62: 719-22.
3. Stewart H, Black G, Donnai, D, et al. A mutation within exon 14 of the TGFBI (BIG-H3) gene on chromosome 5q31 causes an aysmmetrical, late-onset form of lattice corneal dystrophy. Ophthalmology (in press).
4. Maury CPJ, Kere J, Tolvanen R, et al. Finnish hereditary amyloidosis is caused by a single nucleotide sustitution in the gelsolin gene. FEBS Lett 1990;276:75-7.
5. Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy , skin changes, and various internal symptoms: a previously unrecognized heritable syndrome. Ann Clin Res 1969;1: 314-24.
6. Donders PC, Blanksma LJ. Meretoja syndrome. Lattice corneal dystrophy of the cornea with hereditary generalized amyloidosis. Ophthalmologica 1979;178:173-80.
7. Sambrook J, Frisch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, 1989.
8. Kwiatkowski DJ, Perman S. Dinucleotide repeat polymorphism at the GSN locus (9q32-34). Nucleic Acid Res 1991; 19:967.
9. Merril CR, Switzer RC, Van Keuren ML. Trace polypeptides in cellular extracts and human body fluids detected by two-dimensional electrophoresis and a highly sensitive silver stain. Proc Natl Acad Sci USA 1979;16:4335-9.
10. Ellis R. Molecular diagnosis of genetic diseases. 1st ed. London: Humana Press, 1996:Chapter 2:17-35.
11. Sterner RD, Paunio T, Uemichi T et al. Asp187Asn mutation of gelsolin in an American kindred with familial amyloidosis, Finnish type (FAP IV). Hum Genet 1995;95: 327-30.
12. de la Chapelle A, Tolvanen R, Boysen G, et al. Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet 1992;2:157-60.
13. Hida T, Tsubota K, Kigasawa K, et al. Clinical features of a newly recognized type of lattice corneal dystrophy. Am J Ophthalmol 1987;104:241-8.
14. Hida T, Proia AD, Kigasawa K, et al. Histopathologic and immunochemical features of lattice corneal dystrophy type III. Am J Opthalmol 1987;104:249-54.
15. Kivela T, Tarkkanen A, Frangione B, et al. Ocular amyloid deposition in familial amyloidosis, Finnish: an analysis of native and variant gelsolin in Meratoja's syndrome. Invest Ophthalmol Vis Sci 1994;35:3759-69.
16. Sack GH Jr, Dumars KW, Gummerson KS, et al. Three forms of dominant amyloid neuropathy. Johns Hopkins Med J 1981;149:239-47.
17. Boysen G, Galassi G, Kamieniecka Z, et al. Familial amyloidosis with cranial neurpathy and lattice corneal dystrophy. J Neurol Neurosurg Psychiatry 1979;42:1020-30
18. Tsundo I, Awano H, Kayama H, et al. Idiopathic AA amyloidosis manifested by autonomic neuropathy, vestibulocochleopathy and lattice corneal dytstophy. J Neurol Neurosurg Psychiatry 1994;5:635-7.
19. Maury CPJ. Isolation and characterization ot cardiac amyloid in familial amyloid polyneuropathy type IV (Finnish): relation of the amyloid protein to variant gelsolin. Biochim Biophys Acta 1990;1096:84-6.
20. Haltia M, Ghiso J, Prelli F, et al. Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Path 1992;136:1223-8.
21. Witke W, Sharpe AH, Hartwig JH, et al. Hemostatic, inflammatory and fibroblast responses are blunted in mice lacking gelsolin. Cell 1995;81:41-51.
22. Sanuda Y, Shimizu T, Nakase H, et al. Inherited amyloid polyneuropathy IV (gelsolin variant) an a Japanese family. Ann Neurol 1993;33:57-62.
23. Paunio T, Sunada Y, Kiuru S, et al. Haplotype analysis in gelsolin-related amyloidosis reveals independent origin of identical mutation (G654-A) in Finland and Japan. Human Mutation 1995;6:60-5.
24. Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF) and its variants found worldwide. Amyloid - Int J Exp Clin Invest 1998;5:55-66.
25. Kiuru S, Matikainen E, Kupari M, et al. Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF). J Neurol Sci 1994;126:40-8.
26. Maury CP. Homozygous familial amyloidosis, Finnish type: demonstration of glomerular gelsolin-derived amyloid and non-amyloid tubular gelsolin. Clin Nephrol 1993;40:53-6.
27. Fernandez AL, Herreros JM, Monzonis AM, et al. Heart transplantation for Finnish type familial systemic amyloidosis. Scand Cardiovasc J 1997;31:357-9.
28. Stark T, Kenyon KR, Hanninen LA, et al. Clinical and histopathologic studies of two families with lattice corneal dystrophy and familial systemic amyloidosis (Meretoja syndrome). Ophthalmology 1991;98:1197-206.
29. Kiuru S, Familial amyloidosis of the Finnish type (FAF). A clinical study of 30 patients. Acta Neurol Scand 1992;86: 346-53.
30. Kiuru S, Seppalainen AM. Neuropathy in familial amyloidosis Finnish type (FAF): electrophysiological studies. Muscle and Nerve 1994;17:299-304.